TG Therapeutics (TGTX) Misses Q3 EPS by 5c, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| TG THERAP (NASDAQ: TGTX) | Delayed: 61.63 +0.88 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.75 | 52 Week High | $14.87 | |||
| Open | $61.85 | 52 Week Low | $4.90 | |||
| Day High | $62.78 | P/E | N/A | |||
| Day Low | $60.31 | EPS | $-0.67 | |||
| Volume | 2,039,622 | |||||
